Medicamen Biotech Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 386.65 million compared to INR 227.54 million a year ago. Revenue was INR 390.12 million compared to INR 230.91 million a year ago. Net income was INR 37.69 million compared to INR 27.45 million a year ago. Basic earnings per share from continuing operations was INR 3.03 compared to INR 2.25 a year ago. Diluted earnings per share from continuing operations was INR 3.03 compared to INR 2.25 a year ago.
For the full year, sales was INR 1,408.67 million compared to INR 1,154.45 million a year ago. Revenue was INR 1,433.3 million compared to INR 1,171.65 million a year ago. Net income was INR 148.44 million compared to INR 148.97 million a year ago. Basic earnings per share from continuing operations was INR 11.82 compared to INR 12.19 a year ago. Diluted earnings per share from continuing operations was INR 11.82 compared to INR 12.19 a year ago.